Udemy (UDMY) 10-Q 3 May 23 2023 Q1 Quarterly report Financial data

Cover

Cover - shares	3 Months Ended
	Mar. 31, 2023	Apr. 26, 2023
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Mar. 31, 2023
Document Transition Report	false
Entity File Number	001-40956
Entity Registrant Name	Udemy, Inc.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	27-1779864
Entity Address, Address Line One	600 Harrison Street
Entity Address, Address Line Two	3rd Floor
Entity Address, City or Town	San Francisco
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	94107
City Area Code	415
Local Phone Number	813-1710
Title of 12(b) Security	Common Stock, $0.00001 par value
Trading Symbol	UDMY
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		146,774,569
Amendment Flag	false
Document Fiscal Period Focus	Q1
Document Fiscal Year Focus	2023
Entity Central Index Key	0001607939
Current Fiscal Year End Date	--12-31

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Current assets:
Cash and cash equivalents	$ 275,633	$ 313,685
Marketable securities	169,613	151,687
Accounts receivable, net	96,423	104,530
Prepaid expenses and other current assets	17,418	14,878
Deferred contract costs, current	35,929	30,234
Total current assets	595,016	615,014
Property and equipment, net	6,206	7,012
Capitalized software, net	29,045	27,412
Operating lease right-of-use assets	9,849	11,377
Restricted cash, non-current	3,629	3,629
Deferred contract costs, non-current	36,510	35,411
Strategic investments	12,104	12,104
Intangible assets, net	8,264	9,331
Goodwill	12,646	12,646
Other assets	3,631	3,632
Total assets	716,900	737,568
Current liabilities:
Accounts payable	10,792	14,529
Accrued expenses and other current liabilities	26,420	31,247
Content costs payable	35,019	37,310
Accrued compensation and benefits	27,335	22,882
Operating lease liabilities, current	6,910	7,002
Deferred revenue, current	276,050	273,937
Total current liabilities	382,526	386,907
Operating lease liabilities, non-current	4,920	6,545
Deferred revenue, non-current	4,348	4,342
Other liabilities, non-current	21	464
Total liabilities	391,815	398,258
Note 8 – Commitments and contingencies
Stockholders' equity:
Preferred stock, $0.00001 par value - 50,000,000 shares authorized; zero shares issued and outstanding as of March 31, 2023, and December 31, 2022.	0	0
Common stock, $0.00001 par value - 950,000,000 shares authorized; 146,627,024 and 145,013,786 shares issued and outstanding as of March 31, 2023, and December 31, 2022, respectively.	1	1
Additional paid-in capital	982,128	951,946
Accumulated other comprehensive loss	(96)	(233)
Accumulated deficit	(656,948)	(612,404)
Total stockholders’ equity	325,085	339,310
Total liabilities and stockholders' equity	$ 716,900	$ 737,568

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares	Mar. 31, 2023	Dec. 31, 2022
Statement of Financial Position [Abstract]
Preferred stock, par value (in dollars per share)	$ 0.00001	$ 0.00001
Preferred stock, shares authorized (in shares)	50,000,000	50,000,000
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Common stock, par value (in dollars per share)	$ 0.00001	$ 0.00001
Common stock, shares authorized (in shares)	950,000,000	950,000,000
Common stock, shares issued (in shares)	146,627,024	145,013,786
Common stock, shares outstanding (in shares)	146,627,024	145,013,786

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Income Statement [Abstract]
Revenue	$ 176,430	$ 152,223
Cost of revenue	76,701	66,438
Gross profit	99,729	85,785
Operating expenses
Sales and marketing	79,657	66,878
Research and development	30,887	22,570
General and administrative	26,334	21,653
Restructuring charges	10,128	0
Total operating expenses	147,006	111,101
Loss from operations	(47,277)	(25,316)
Other income (expense)
Interest income, net	3,932	243
Other expense, net	(142)	(244)
Total other income (expense), net	3,790	(1)
Net loss before taxes	(43,487)	(25,317)
Income tax provision	(1,057)	(332)
Net loss	(44,544)	(25,649)
Net loss	$ (44,544)	$ (25,649)
Net loss per share
Basic (in dollars per share)	$ (0.31)	$ (0.18)
Diluted (in dollars per share)	$ (0.31)	$ (0.18)
Weighted-average shares used in computing net loss per share
Basic (in shares)	145,737,709	139,405,294
Diluted (in shares)	145,737,709	139,405,294

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Statement of Comprehensive Income [Abstract]
Net loss	$ (44,544)	$ (25,649)
Net loss	(44,544)	(25,649)
Foreign currency translation gain (loss), net of tax	(11)	10
Change in unrealized loss on marketable securities, net of tax	148	0
Comprehensive loss	$ (44,407)	$ (25,639)

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Stockholders’ Equity - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2021		139,164,693
Beginning balance at Dec. 31, 2021	$ 389,700	$ 1	$ 848,229	$ (1)	$ (458,529)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	14,930		14,930
Exercise of stock options (in shares)		376,578
Exercise of stock options	1,517		1,517
Vesting of restricted stock units (in shares)		32,145
Vesting of restricted stock units	0		0
Cumulative translation adjustment	10			10
Net loss	(25,649)				(25,649)
Ending balance (in shares) at Mar. 31, 2022		139,573,416
Ending balance at Mar. 31, 2022	380,508	$ 1	864,676	9	(484,178)
Beginning balance (in shares) at Dec. 31, 2022		145,013,786
Beginning balance at Dec. 31, 2022	339,310	$ 1	951,946	(233)	(612,404)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	28,733		28,733
Exercise of stock options (in shares)		355,516
Exercise of stock options	1,449		1,449
Vesting of restricted stock units (in shares)		1,257,722
Vesting of restricted stock units	0		0
Other comprehensive loss	137			137	0
Cumulative translation adjustment	(11)
Net loss	(44,544)				(44,544)
Ending balance (in shares) at Mar. 31, 2023		146,627,024
Ending balance at Mar. 31, 2023	$ 325,085	$ 1	$ 982,128	$ (96)	$ (656,948)

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Cash flows from operating activities:
Net loss	$ (44,544)	$ (25,649)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	5,786	4,967
Amortization of deferred sales commissions	10,508	6,582
Stock-based compensation	26,283	13,342
Allowance for credit losses	301	110
Accretion of marketable securities	(1,815)	0
Non-cash operating lease expense	1,572	1,573
Other	375	75
Changes in operating assets and liabilities:
Accounts receivable	7,805	5,371
Prepaid expenses and other assets	(2,434)	198
Deferred contract costs	(17,302)	(13,038)
Accounts payable, accrued expenses and other liabilities	(4,499)	(21,964)
Content costs payable	(2,292)	(4,355)
Operating lease liabilities	(1,759)	(1,151)
Deferred revenue	2,120	19,964
Net cash used in operating activities	(19,895)	(13,975)
Cash flows from investing activities:
Purchases of marketable securities	(58,463)	0
Proceeds from maturities of marketable securities	42,500	0
Purchases of property and equipment	(100)	(156)
Capitalized software costs	(3,256)	(3,121)
Purchases of strategic investments	0	(5,000)
Net cash used in investing activities	(19,319)	(8,277)
Cash flows from financing activities:
Net proceeds from exercise of stock options	1,180	1,658
Payment of deferred offering costs	0	(1,586)
Net cash provided by financing activities	1,180	72
Effect of foreign exchange rates on cash flows	(18)	6
Net decrease in cash, cash equivalents and restricted cash	(38,052)	(22,174)
Cash, cash equivalents and restricted cash—Beginning of period	317,314	536,768
Cash, cash equivalents and restricted cash—End of period	279,262	514,594
Reconciliation of cash, cash equivalents and restricted cash:
Cash and cash equivalents	275,633	510,965
Restricted cash	3,629	3,629
Total cash, cash equivalents and restricted cash	279,262	514,594
Supplemental disclosures of cash flow information:
Interest paid	488	2
Income taxes paid	44	64
Supplemental disclosure of non-cash investing and financing activities:
Stock-based compensation in capitalized costs	2,305	1,311
Change in unrealized loss on marketable securities	$ 149	$ 0

Organization and description of

Organization and description of business	3 Months Ended
	Mar. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization and description of business	1. Organization and description of business Description of business Udemy, Inc. (“Udemy” or the “Company”) was incorporated in January 2010 under the laws of the state of Delaware. The Company is headquartered in San Francisco, California. Udemy is a global learning company whose online platform empowers organizations and individuals with flexible and effective skill acquisition and development. The Company’s learning marketplace platform enables tens of thousands of subject matter experts to develop, distribute and enhance content that reaches Udemy’s broad global audience of learners. Udemy leverages technology, data and insights to deliver personalized and effective learning experiences. The Company further curates its highest-quality content from the marketplace for Udemy Business, which enables companies around the world to offer engaging, effective, on-demand learning for all employees, immersive laboratory-style learning for tech teams, and cohort-based learning focused on leadership development.

Summary of significant accounti

Summary of significant accounting policies	3 Months Ended
	Mar. 31, 2023
Accounting Policies [Abstract]
Summary of significant accounting policies	2. Summary of significant accounting policies Basis of consolidation and presentation — The accompanying condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”). The condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation, and all other normal and recurring adjustments that are, in the opinion of management, necessary for a fair presentation of the results of the periods presented have been made. Segment information — On March 1, 2023, Greg Brown became the Company’s new Chief Executive Officer and chief operating decision maker (“CODM”). The Company defines its segments as those operations the CODM regularly reviews to allocate resources and assess performance. For the three months ended March 31, 2023 and 2022, the Company operated under two operating and reportable segments: Enterprise and Consumer. The Company continually monitors and reviews its segment reporting structure in accordance with Accounting Standards Codification (“ASC”) Topic 280, Segment Reporting, to determine whether any changes have occurred that would impact its reportable segments. For further information on the Com pany’s segment reporting, see Note 13 – Segment and geographic information. Use of estimates — The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the condensed consolidated financial statements and the results of operations during the reporting periods. Significant estimates and assumptions reflected in the condensed consolidated financial statements include, but are not limited to, allowance for credit losses, capitalization of internally developed software and ass ociated useful lives, stock-based compensation, determination of the income tax valuation allowance and the potential outcome of uncertain tax positions, estimated instructor withholding tax obligations, estimated service period for consumer single course purchases, the period of benefit for deferred commissions, t he fair value and associated useful lives of intangible assets and goodwill acquired via business combinations, and the valuation of privately-held strategic investments, including impairments. Management periodically evaluates such estimates and assumptions for continued reasonableness. Actual results may ultimately differ from management’s estimates and such differences could be material to the Company’s financial position and results of operations. Concentration of credit risk — Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents, marketable securities, restricted cash, and accounts receivable. For cash and restricted cash, the Company is exposed to credit risk in the event of default by the financial institutions to the extent the amounts recorded on the accompanying condensed consolidated balance sheets are in excess of federal insurance limits. The Company’s investments, classified as cash equivalents and marketable securities, consist of high-credit-quality instruments and fixed-income securities. The Company generally does not require collateral or other security in support of accounts receivable. To reduce credit risk, management performs ongoing evaluations of its customers’ financial condition and maintains an allowance based upon expected credit losses of outstandin g receivables. The Company had one customer, a reseller partner for the Enterprise segment, who accounted for more than 10% of total accounts receivable as of March 31, 2023. The Company had no customers which accounted for more than 10% of total accounts receivable as of December 31, 2022. No customer accounted for more than 10% of total revenue during the three months ended March 31, 2023 or 2022. Summary of significant ac counting policies— Except as described below, there were no significant changes to the Company’s significant accounting policies disclosed in Note 2 – Summary of significant accounting policies of the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2022, which was filed with the SEC on February 27, 2023 (the “Annual Report”). Stock-based compensation — The Company accounts for its stock-based compensation pursuant to ASC Topic 718, Compensation-Stock Compensation. The Company granted performance-based restricted stock units (“PSUs”) in the first quarter of 2023, which vest based on the achievement of predefined corporate performance metrics and are subject to ongoing service conditions. The Company determines the fair value of PSUs based on the fair value of the Company’s common stock on the date of grant. Because PSUs have both performance and service-based vesting conditions, the Company separately attributes stock-based compensation expense for each vesting tranche of the award over their requisite service periods. Management estimates the number of PSUs that are expected to vest based on the anticipated achievement of the specified performance metrics. If the performance-based vesting condition is considered probable of being achieved, the Company recognizes expense over the requisite service period based on the probable outcome of achievement. If the performance goals are not met, or are considered improbable, no compensation cost is recognized, and any previously recognized compensation cost is reversed. Accounts receivable, net — Accounts receivable primarily represent amounts owed to the Company for Enterprise subscriptions. Also included in accounts receivable are amounts due from payment processors or mobile application store partners that settle over a period longer than five business days. Accounts receivable balances are recorded at the invoiced amount and are non-interest-bearing. Accounts receivable is presented net of allowance for credit losses in the accompanying condensed consolidated balance sheets. The Company maintains an allowance based upon expected credit losses of outstanding receivables. Management derives its estimate using a variety of factors, including historical collection and loss patterns; the current aging of receivables; geographic and other customer-specific credit risk factors; and reasonable and supportable forecasts of future economic conditions which inform adjustments to historical loss patterns. The provision for expected credit losses is recorded in general and administrative expenses in the accompanying condensed consolidated statements of operations. Accounts receivable deemed to be uncollectible are written off, net of expected or actual recoveries. Balance at Beginning of Period Charged to Expenses Charges Utilized/Written-off, Net of Recoveries Balance at End of Period Allowance for credit losses (in thousands) Three Months Ended March 31, 2023 $ 1,528 $ 301 $ (213) $ 1,616 Three Months Ended March 31, 2022 $ 678 $ 110 $ (110) $ 678 Self-insurance — Beginning in 2023, the Company became self-insured for medical benefits offered to certain employees, up to certain stop-loss limits. Such costs are accrued based on known claims and estimates of incurred but not reported (“IBNR”) claims. IBNR claims are estimated using historical claim information and actuarial estimates. As of March 31, 2023, the accrued liability for self-insurance totaled $1.0 million and is included in accrued compensation and benefits on the condensed consolidated balance sheets. Recently Adopted Accounting Pronouncements Recently Issued Accounting Pronouncements Not Yet Adopted

Revenue recognition

Revenue recognition	3 Months Ended
	Mar. 31, 2023
Revenue from Contract with Customer [Abstract]
Revenue recognition	3. Revenue recognition Deferred revenue — Revenue recognized for the three months ended March 31, 2023, from amounts included in deferred revenue as of December 31, 2022 was $134.6 million. R evenue recognized for the three months ended March 31, 2022, from amounts included in deferred revenue as of December 31, 2021 was $111.4 million. The below table presents a summary of deferred revenue balances by reportable segment (in thousands): March 31, December 31, December 31, 2023 2022 2021 Deferred revenue: Enterprise $ 221,157 $ 219,030 $ 148,966 Consumer 59,241 59,249 61,588 Total deferred revenue $ 280,398 $ 278,279 $ 210,554 Remaining performance obligations — Remaining performance obligations represent the aggregate amount of the transaction price in contracts for performance obligations not delivered, or partially undelivered, as of the end of the reporting period. Remaining performance obligations primarily relate to unearned and unbilled revenue from multi-year Enterprise subscription contracts with future installment payments, as well as unearned revenue from Consumer single course purchases and subscriptions at the end of any given period. As of March 31, 2023, the aggregate transaction price for remaining performance ob ligations was $502.3 million, of which 70% is expected to be recognized over the next twelve months and the remainder thereafter. Deferred contract costs — The following table represents a rollforward of the Company’s deferred contract costs (in thousands): Balance at Beginning of Period Additions Amortization Expense Balance at End of Period Three Months Ended March 31, 2023 $ 65,645 $ 17,302 $ (10,508) $ 72,439 Three Months Ended March 31, 2022 $ 44,545 $ 13,038 $ (6,582) $ 51,001

Investments and fair value meas

Investments and fair value measurements	3 Months Ended
	Mar. 31, 2023
Fair Value Disclosures [Abstract]
Investments and fair value measurements	4. Investments and fair value measurements The Company’s assets and liabilities that are measured at fair value on a recurring or nonrecurring basis within the fair value hierarchy are as follows (in thousands): As of March 31, 2023 Level 1 Level 2 Level 3 Cash equivalents: Money market funds $ 237,819 $ — $ — Marketable securities: U.S. government securities $ — $ 169,613 $ — Non-current assets: Strategic investments $ — $ — $ 12,104 Current liabilities— accrued compensation and benefits: Cash settled stock appreciation rights $ — $ — $ 243 Non-current liabilities: Cash settled stock appreciation rights $ — $ — $ 21 As of December 31, 2022 Level 1 Level 2 Level 3 Cash equivalents: Money market funds $ 130,377 $ — $ — U.S. government securities — 48,900 — Total cash equivalents $ 130,377 $ 48,900 $ — Marketable securities: U.S. government securities $ — $ 151,687 $ — Non-current assets: Strategic investments $ — $ — $ 12,104 Non-current liabilities: Cash settled stock appreciation rights $ — $ — $ 462 The Company’s money market funds are classified within Level 1 of the fair value hierarchy because they are valued using quoted prices in active markets. The Company’s investments in U.S. government securities are classified within Level 2 of the fair value hierarchy because they have been valued using inputs other than quoted prices in active markets that are directly or indirectly observable. The Company’s strategic investment and stock appreciation rights (“SARs”) are classified within Level 3 of the fair value hierarchy because they have been valued using significant unobservable inputs for which the Company has been required to develop its own assumptions. A summary of the changes in the fair value of Level 3 financial instruments, of which remeasurement of SARs are recognized in the condensed consolidated statements of operations, is as follows (in thousands): Stock Appreciation Rights Strategic Investments Balance— December 31, 2022 $ 462 $ 12,104 Vesting and remeasurement of SARs (198) — Balance— March 31, 2023 $ 264 $ 12,104 Balance— December 31, 2021 $ 818 $ 10,000 Vesting and remeasurement of SARs, net (310) — Purchases of strategic investments — 5,000 Balance— March 31, 2022 $ 508 $ 15,000

Consolidated balance sheet comp

Consolidated balance sheet components	3 Months Ended
	Mar. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Consolidated balance sheet components	5. Consolidated balance sheet components Cash, cash equivalents, and marketable securities — The amortized cost, unrealized gains and losses, and estimated fair value of cash, cash equivalents, and marketable securities consisted of the following (in thousands): As of March 31, 2023 Amortized Cost Unrealized Gains Unrealized Losses Fair Value Cash and cash equivalents: Cash $ 37,814 $ — $ — $ 37,814 Money market funds 237,819 — — 237,819 Total cash and cash equivalents 275,633 — — 275,633 Marketable securities: U.S. government securities 169,677 40 (104) 169,613 Total cash, cash equivalents, and marketable securities $ 445,310 $ 40 $ (104) $ 445,246 As of December 31, 2022 Amortized Cost Unrealized Gains Unrealized Losses Fair Value Cash and cash equivalents: Cash $ 134,408 $ — $ — $ 134,408 Money market funds 130,377 — — 130,377 U.S. government securities 48,899 4 (3) 48,900 Total cash and cash equivalents 313,684 4 (3) 313,685 Marketable securities: U.S. government securities 151,900 30 (243) 151,687 Total cash, cash equivalents, and marketable securities $ 465,584 $ 34 $ (246) $ 465,372 Cash equivalents and marketable securities in an unrealized loss position consisted of the following (in thousands): March 31, 2023 December 31, 2022 Fair Value Gross Unrealized Losses Fair Value Gross Unrealized Losses Cash equivalents: U.S. government securities $ — $ — $ 24,960 $ (3) Marketable securities: U.S. government securities 37,102 (104) 59,057 (243) Total securities in an unrealized loss position $ 37,102 $ (104) $ 84,017 $ (246) Realized gains and losses reclassified from accumulated other comprehensive loss to other income (expense), net were zero for the three months ended March 31, 2023. No securities had been in a continuous unrealized loss position for twelve months or longer as of March 31, 2023 or December 31, 2022. The Company does not intend to sell available-for-sale marketable debt securities in unrealized loss positions, and it is more likely than not that the Company will hold these securities until maturity or recovery of the cost basis. As of March 31, 2023 and December 31, 2022, the Company did not have an allowance for credit losses related to its available-for-sale debt securities due to a zero loss expectation for the portfolio which consists solely of U.S. government securities. As of March 31, 2023, the entirety of the Company’s marketable securities portfolio had remaining contractual maturities of one year or less. Property and equipment, net — Property and equipment, net consisted of the following (in thousands): March 31, December 31, 2023 2022 Computers and equipment $ 7,756 $ 7,820 Furniture and fixtures 4,678 4,870 Purchased software 383 383 Leasehold improvements 19,017 19,109 Construction in progress 8 — Total property and equipment 31,842 32,182 Less accumulated depreciation and amortization (25,636) (25,170) Property and equipment, net $ 6,206 $ 7,012 Depreciation expense w as $0.8 million and $1.2 million for the three months ended March 31, 2023 and 2022, respectively. Capitalized software, net — Capitalized software, net consisted of the following (in thousands): March 31, December 31, 2023 2022 Capitalized software $ 69,284 $ 63,748 Less accumulated amortization (40,239) (36,336) Capitalized software, net $ 29,045 $ 27,412 Amortization expense of capitalized softwar e was $3.9 million and $2.7 million for the three months ended March 31, 2023 and 2022, respectively. As of March 31, 2023, expected amortization expense for capitalized software over the remaining asset lives was as follows (in thousands): Remainder of 2023 $ 11,583 2024 11,496 2025 5,630 2026 336 Total expected amortization $ 29,045 Intangible assets, net and goodwill— As of March 31, 2023, intangible assets, net acquired as part of the CorpU business combination were as follows (in thousands): Estimated Useful Lives Intangible Assets, Gross Accumulated Amortization Intangible Assets, Net Customer relationships 6 years $ 5,500 $ (1,469) $ 4,031 Vendor relationships 3 years 4,500 (2,403) 2,097 Developed technology 3 years 4,200 (2,243) 1,957 Tradename 2 years 900 (721) 179 Total $ 15,100 $ (6,836) $ 8,264 As of December 31, 2022, intangible assets, net acquired as part of the CorpU business combination were as follows (in thousands): Estimated Useful Lives Intangible Assets, Gross Accumulated Amortization Intangible Assets, Net Customer relationships 6 years $ 5,500 $ (1,239) $ 4,261 Vendor relationships 3 years 4,500 (2,028) 2,472 Developed technology 3 years 4,200 (1,893) 2,307 Tradename 2 years 900 (609) 291 Total $ 15,100 $ (5,769) $ 9,331 Amortization expense of intangible assets for the three months ended March 31, 2023 and 2022 was $1.1 million and $1.1 million, respectively. The expected future amortization expense for intangible assets as of March 31, 2023 was as follows (in thousands): Remainder of 2023 $ 3,041 2024 2,795 2025 917 2026 917 2027 594 Total expected amortization $ 8,264 Goodwill in the amount of $12.6 million was established as part of the CorpU acquisition on August 24, 2021, and allocated to the Enterprise segment. This amount represents the excess of the purchase price over the fair value of net assets acquired. There have been no adjustments to the carrying amount of goodwill as of March 31, 2023. The Company tests for impairment at least annually, or whenever events or changes in circumstances occur that could impact the recoverability of these assets. No such triggering events were noted for the three months ended March 31, 2023 and 2022.

Leases

Leases	3 Months Ended
	Mar. 31, 2023
Leases [Abstract]
Leases	6. Leases The Company applies the guidance under Topic 842 for leases of real estate facilities under non-cancelable operating leases with various expiration dates through fiscal year 2026. The Company recognized the following amounts related to its operating leases in its condensed consolidated statements of operations and cash flows (in thousands): Three Months Ended March 31, 2023 2022 Operating lease costs $ 1,670 $ 1,701 Variable lease costs $ 314 $ 204 Cash paid for operating leases $ 1,923 $ 1,151 Future minimum lease payments under noncancellable operating leases with initial lease terms in excess of one year as of March 31, 2023, were as follows (in thousands): 2023 $ 5,279 2024 5,790 2025 809 2026 410 Gross lease payments 12,288 Less imputed interest (458) Present value of operating lease liabilities $ 11,830

Accrued expenses and other curr

Accrued expenses and other current liabilities	3 Months Ended
	Mar. 31, 2023
Payables and Accruals [Abstract]
Accrued expenses and other current liabilities	7. Accrued expenses and other current liabilities Accrued expenses and other current liabilities consist of the following (in thousands): March 31, December 31, 2023 2022 Accrued expenses $ 7,262 $ 8,494 Indirect tax reserves 4,158 6,627 Indirect tax payables 7,968 9,137 Other current liabilities 7,032 6,989 Accrued expenses and other current liabilities $ 26,420 $ 31,247 Indirect tax payables relate to amounts collected from customers on behalf of third-party taxing authorities, primarily on sales in the U.S. and in international jurisdictions. Indirect tax payables also include withholding taxes on payments made to the Company’s instructors before remitting these amounts to the taxing authorities. As of March 31, 2023, indirect tax reserves consist of the residual interest payable on the Company’s instructor withholding tax reserves and other indirect tax reserves. Instructor withholding tax reserves — Prior to March 2020, the Company had not obtained appropriate taxpayer identification forms from instructors, nor remitted applicable tax withholding amounts to the U.S. Internal Revenue Service (“IRS”) where required. In accordance with GAAP, the Company recorded a provision for its tax exposure when it was both probable that a liability had been incurred and the amount of the exposure could be reasonably estimated. Beginning in March 2020, the Company began collecting appropriate taxpayer identification forms from its instructors, assessing whether the forms justified a reduced rate of withholding or withholding exemption, and remitting withholding tax payments to the IRS where required. The Company also began reporting payments to its non-U.S. instructors and the IRS annually where required to do so. In 2020, the Company approached the IRS to address the historical tax withholding amounts for instructors and engaged in a voluntary disclosure program. As of March 31, 2023, the Company has filed all outstanding withholding tax returns and has paid the associated tax obligation to the IRS. The estimated interest associated with the reserve is still outstanding. Changes in the estimated amount the Company has determined it will owe are recorded in general and administrative expenses in the accompanying condensed consolidated statements of operations. Estimated interest is recorded in interest income (expense), net in the accompanying condensed consolidated statement of operations. Changes to the instructor withholding tax reserve are as follows (in thousands): Three Months Ended March 31, 2023 2022 Balance, beginning of period $ 2,528 $ 17,036 Amounts charged to (released from) expense 44 (1,343) Net payments and settlements — — Balance, end of period $ 2,572 $ 15,693

Commitments and contingencies

Commitments and contingencies	3 Months Ended
	Mar. 31, 2023
Commitments and Contingencies Disclosure [Abstract]
Commitments and contingencies	8. Commitments and contingencies Noncancellable purchase commitments — The Company has contractual commitments with its cloud infrastructure provider, network service providers and paid advertising vendors that are noncancellable. As of March 31, 2023, the Company had $55.4 million w orth of future minimum payments under the Company’s noncancellable purchase commitments which are expected to be paid through 2026. Indemnification — The Company enters into indemnification provisions under agreements with other parties in the ordinary course of business, including certain business partners, investors, contractors, and the Company’s officers, directors, and certain employees. The Company has agreed to indemnify and defend the indemnified party’s claims and related losses suffered or incurred by the indemnified party resulting from actual or threatened third-party claims because of the Company’s activities or, in some cases, non-compliance with certain representations and warranties made by the Company. In general, the Company does not record any liability for these indemnities in the accompanying condensed consolidated balance sheets as the amounts cannot be reasonably estimated and are not considered probable. The Company does, however, accrue for losses for any known contingent liability, including those that may arise from indemnification provisions, when future payment is probable. To date, losses recorded in the Company’s condensed consolidated statements of operations in connection with the indemnification provisions have not been material. Litigation — From time to time, in the ordinary course of business, the Company is subject to legal proceedings, claims, investigations, and other proceedings, including claims of alleged infringement of third-party patents and other intellectual property rights, and commercial, employment, and other matters. In accordance with generally accepted accounting principles, the Company makes a provision for a liability when it is both probable that a liability has been incurred and the amount of the loss can be reasonably estimated. These provisions are reviewed at least annually and adjusted to reflect the impacts of negotiations, settlements, rulings, advice of legal counsel, and other information and events pertaining to a particular case. The outcome of such litigation is not expected to have a material effect on the financial position, results of operation and cash flows of the Company. The Company has recorded an immaterial amount related to all outstanding litigation matters in the accompanying condensed consolidated balance sheets, within accrued expenses and other current liabilities as of March 31, 2023, and December 31, 2022.

Income taxes

Income taxes	3 Months Ended
	Mar. 31, 2023
Income Tax Disclosure [Abstract]
Income taxes	9. Income taxes The provision for income taxes for interim periods is determined using an estimate of the Company’s annual effective tax rate, adjusted for discrete items, if any, that are taken into consideration in the relevant period. Each quarter, the Company updates the estimate of the annual effective tax rate, and if the estimated tax rate changes, the Company records a cumulative adjustment to the provision. The Company had an effective tax rate of (2.43)% and (1.30)% for the three months ended March 31, 2023 and 2022, respectively. The difference between the 21% statutory federal tax rate and the effective tax rate was primarily a result of income earned in jurisdictions with higher statutory tax rates, foreign withholding taxes, and tax credits offset by change in valuation allowance. As of March 31, 2023 and December 31, 2022, the Company has provided a valuation allowance against U.S. federal and state deferred tax assets. Management continues to evaluate the realizability of deferred tax assets and the related valuation allowance. If management's assessment of the deferred tax assets or the corresponding valuation allowance were to change, the Company would record the related adjustment to income during the period in which management makes the determination. The Company recognizes interest and penalties associated with uncertain tax positions as part of the income tax provision. To date, the Company has not recognized any interest and penalties in its condensed consolidated statements of operations, nor has it accrued for or made payments for interest and penalties. The Company is subject to taxation in the U.S. and various foreign jurisdictions. Due to NOL carryforwards and tax credit carryforwards, the statutes of limitations remain open for tax years from inception of the Company through 2022. There are currently no income tax audits underway by U.S. federal or state tax authorities. There are income audits in Turkey and India that began in the year ended December 31, 2022, but no notices or assessments have been issued at this time.

Related party transactions

Related party transactions	3 Months Ended
	Mar. 31, 2023
Related Party Transactions [Abstract]
Related party transactions	10. Related party transactions Naspers Ltd. (“Naspers”), through an investment entity controlled by Prosus N.V. (“Prosus”), beneficially owns more than 5% of the Company’s outstanding capital stock. A current member of the Company’s Board of Directors is an executive officer of a Prosus operating subsidiary, OLX Global B.V. A former member of the Company’s Board of Directors, who resigned in September 2022, was an executive officer of Prosus. Naspers and cer tain entities directly and indirectly controlled by Naspers are customers of the Company’s Enterprise subscription offering. The Company recorded $0.3 million and $0.4 million of revenue from services provided to these customers during the three months ended March 31, 2023 and 2022, respectively. As of March 31, 2023 and December 31, 2022, the Company had an accounts receivable balance of $0.1 million with these customers. Insight Partners, where a member of the Company’s Board of Directors is a Managing Director, is affiliated with certain vendors that the Company has contracted to provide technology and software solutions. For each of the three months ended March 31, 2023 and 2022, the Company recorded $0.2 million of operating expenses with these vendors. The Company did not have an accounts payable balance with these vendors as of March 31, 2023 or December 31, 2022. Certain members of the Company’s Board of Directors also serve as executive officers for customers of the Company’s Enterprise subscription offering. During the three months ended March 31, 2023 and 2022, the Company recorded $0.1 million and an immaterial amount, respectively, of revenue from services provided to these customers. As of March 31, 2023 and December 31, 2022, the Company had an accounts receivable balance with these customers of zero and $0.4 million, respectively.

Stockholders' equity

Stockholders' equity	3 Months Ended
	Mar. 31, 2023
Share-Based Payment Arrangement [Abstract]
Stockholders' equity	11. Stockholders' equity Preferred stock — In connection with the IPO, the Company’s amended and restated certificate of incorporation became effective, which authorized the issuance of 50,000,000 shares of undesignated preferred stock with a par value of $0.00001 per share with rights and preferences, including voting rights, designated from time to time by the board of directors. Common stock — Common stockholders are entitled to one vote per share. As of March 31, 2023 and December 31, 2022, the following shares of common stock were available for future issuance: March 31, December 31, 2023 2022 2010 Equity Incentive Plan: Stock options outstanding 9,925,732 10,333,771 2021 Equity Incentive Plan: RSUs outstanding and PSUs (1) 17,713,184 16,178,101 Shares available for future issuance under: 2021 Equity Incentive Plan 7,324,533 2,814,126 2021 Employee Stock Purchase Plan 3,379,715 1,929,578 Total shares of common stock reserved 38,343,164 31,255,576 (1) The number of PSUs reserved for issuance is based on the maximum achievement of the corporate performance metric. Equity incentive plans — In 2010, the Company adopted the 2010 Equity Incentive Plan (the “2010 Plan”). The 2010 Plan provided for incentive stock options (“ISOs”), non-statutory stock options (“NSOs”, collectively with ISOs, “stock options”), SARs, restricted stock, and restricted stock units (“RSUs”) to be granted to eligible employees, directors, and consultants. The 2010 Plan was terminated in October 2021 in connection with the IPO but continues to govern the terms and conditions of the outstanding awards granted pursuant to the 2010 Plan. No further equity awards will be granted under the 2010 Plan. The Company adopted the 2021 Equity Incentive Plan (the "2021 Plan") in September 2021, which became effective on October 28, 2021 (collectively with the 2010 Plan, the “Equity Incentive Plans”) and was approved by the Company’s stockholders. The 2021 Plan provides for the granting of ISOs, NSOs, SARs, restricted stock, RSUs, and performance awards to eligible employees, directors, and consultants. The Company initially reserved 13,800,000 shares for issuance under the 2021 Plan. The amount available for issuance is subject to an annual increase on the first day of each calendar year, beginning on January 1, 2023, in an amount equal to 5% of the outstanding shares of the Company’s common stock on the last day of the immediately preceding calendar year or a lesser amount determined by the Company’s Board of Directors or compensation committee. The amount available for issuance shall also include Returning Shares, which are any shares subject to awards granted under the 2010 Plan that, on or after October 29, 2021, expire or otherwise terminate without having been exercised in full, are tendered to or withheld by the Company for payment of an exercise price or for tax withholding obligations, or are forfeited to or repurchased by the Company due to failure to vest. On January 1, 2023, the shares available for future grants under the 2021 Plan automatically increased by 7,250,689 pursuant to the above evergreen provision of the 2021 Plan. Stock options — The Company may grant stock options at exercise prices not less than the fair market value at the date of grant. These options generally expire 10 years from the date of grant. The Company recognizes stock-based compensation expense on a straight-line basis over the requisite service period for each award, which is generally even over four years. The following is a summary of activity for stock options having only service-based vesting conditions under the Equity Incentive Plans: Options Outstanding Weighted Average Exercise Price Weighted Average Remaining Contractual Term Aggregate Intrinsic Value Balance - December 31, 2022 10,283,771 $ 4.18 6.38 $ 66,234 Granted — — Exercised (355,516) 4.10 Canceled (52,523) 11.28 Balance - March 31, 2023 9,875,732 $ 4.15 3.06 $ 47,212 Vested & expected to vest as of March 31, 2023 9,875,732 $ 4.15 3.06 $ 47,212 Exercisable as of March 31, 2023 8,973,521 $ 3.92 2.89 $ 44,616 There were no stock options granted during the three months ended March 31, 2023 or 2022. The decrease in weighted average remaining contractual term during the period is due to stock options held by the Company’s former CEO, Mr. Coccari, which will expire if not exercised by the end of the 90-day post-termination exercise window that begins upon completion of his transition agreement in February 2024. Refer to further discussion below under other equity transactions. As of March 31, 2023, total unrecognized stock-based compensation expense related to unvested stock options was $2.2 million, which will be recognized over a weighted average period of 0.8 years. Stock appreciation rights — The Company may grant SARs at exercise prices not less than the fair market value at the date of grant. The SARs are liability-classified awards that generally expire 10 years from the date of grant. The Company recognizes stock-based compensation expense on a straight-line basis over the requisite service period for each award, which is generally even over four years. The following is a summary of activity for SARs under the Equity Incentive Plans: SARs Outstanding Weighted Average Exercise Price Weighted Average Remaining Contractual Term Aggregate Intrinsic Value Balance - December 31, 2022 81,770 $ 5.44 6.90 $ 418 Granted — — Exercised — — Canceled (9,289) 6.58 Balance - March 31, 2023 72,481 $ 5.29 0.57 $ 257 Vested & expected to vest as of March 31, 2023 72,481 $ 5.29 0.57 $ 257 Exercisable as of March 31, 2023 71,706 $ 5.28 0.50 $ 254 There were no SARs granted during the three months ended March 31, 2023 or 2022. The decrease in weighted average remaining contractual term during the period is due to SARs held by employees impacted by the workforce reduction, as described in Note 14. Such SARs will expire if not exercised by the end of their respective 90-day post-termination exercise windows. As of March 31, 2023, total unrecognized stock-based compensation expense related to unvested SARs was immaterial. Restricted stock units and performance-based restricted stock units — The fair value of RSUs is determined using the fair value of the Company’s common stock on the date of grant. The Company recognizes stock-based compensation expense for RSUs with service-based vesting conditions on a straight-line basis over the requisite service period for each award, which typically vest over a three During the first quarter of 2023, the Company granted 645,833 PSUs to certain executives at target. Each PSU conveys a right to receive one share of the Company’s common stock on the date it vests, provided that the number of PSUs that will ultimately vest may vary from 0% to 150% of target based upon the achievement of the corporate performance metric at the end of the performance period. One quarter of the eligible PSUs vest upon certification of the corporate performance metric in the first quarter of 2024, and the remaining 75% will vest equally over the following 12 quarters thereafter, subject to continual service by the grantee. Total stock-based compensation expense to be recognized may fluctuate during the performance period due to changes in forecasted achievement. The corporate performance metric associated with these awards has been considered probable of being achieved since the grant date, and the Company assumed 100% achievement as of March 31, 2023. A summary of RSU and PSU activity under the 2021 Plan is as follows: RSUs Outstanding Weighted Average Grant Date Fair Value PSUs Outstanding Weighted Average Grant Date Fair Value Unvested - December 31, 2022 16,178,101 $ 17.37 — $ — Granted 2,290,999 $ 9.84 645,833 $ 8.89 Released (1,257,722) $ 17.91 — $ — Canceled (466,926) $ 15.48 — $ — Unvested - March 31, 2023 16,744,452 $ 16.35 645,833 $ 8.89 As of March 31, 2023, total unrecognized stock-based compensation expense related to unvested RSUs was $221.0 million, which will be recognized over a weighted average period of 3.0 years. As of March 31, 2023, total unrecognized stock-based compensation expense related to unvested PSUs was $5.6 million, which will be recognized over a weighted average period of 2.2 years. Performance-based stock options — There have been no other changes to the Company’s performance-based stock options compared to those described in Note 14— Stockholders’ equity, included in Part II, Item 8 of the Company’s Annual Report. As of March 31, 2023, there were 50,000 performance-based stock options outstanding, of which 16,666 were exercisable. As of March 31, 2023, total unrecognized stock-based compensation expense related to unvested performance-based stock options was immaterial. Employee stock purchase plan — The 2021 Employee Stock Purchase Plan (the “ESPP”) became effective on October 29, 2021. The Company initially reserved 2,800,000 shares of the Company's common stock under the ESPP. Shares reserved for issuance shall increase on the first day of the fiscal year, beginning in fiscal 2023, in an amount equal to the least of 1% of the outstanding shares of common stock on the last day of the immediately preceding fiscal year, three times the initial number of shares reserved under the ESPP, or a lesser amount determined by the Company’s Board of Directors or compensation committee. On January 1, 2023, the shares available for future grants under the ESPP automatically increased by 1,450,137 pursuant to the above evergreen provision of the 2021 ESPP. As of March 31, 2023, total unrecognized compensation cost for the ESPP was $6.5 million, which will be recognized over a weighted average period of 1.3 years. Other equity transactions — On February 28, 2023, the Company entered into a transition agreement with Mr. Coccari under which he will provide transition advice through February 28, 2024. During the transition period, he will continue to meet the definition of a service provider under the 2021 Plan, and his equity incentive awards will continue to vest in accordance with their original vesting schedules. Because the scope of services to be provided under the transition period represent a substantive reduction in services being provided by the former CEO, the Company recognize d $3.1 million in stock-based compensation expense during the three months ended March 31, 2023, that would have otherwise been recognized from April 2023 to February 2024. On August 24, 2021, the Company issued 61,300 shares of Udemy restricted common stock to a former executive of CorpU at a grant date fair value per share of $34.14. The total compensation cost recognized during the three months ended March 31, 2023 and 2022 was $0.2 million and $0.2 million, respectively. As of March 31, 2023, total compensation cost related to the restricted stock not yet recognized was $1.0 million, which will be recognized over a weighted average period of 1.4 years. Total stock-based compensation expense included in the condensed consolidated statements of operations was as follows (in thousands): Three Months Ended March 31, 2023 2022 Cost of revenue $ 1,593 $ 840 Sales and marketing 7,277 4,137 Research and development 6,294 3,334 General and administrative 9,911 5,031 Restructuring charges 1,208 — Total stock-based compensation expense $ 26,283 $ 13,342 The Company capitalized $2.3 million and $1.2 million of stock-based compensation expense as capitalized software during the three months ended March 31, 2023 and 2022, respectively.

Net loss per share

Net loss per share	3 Months Ended
	Mar. 31, 2023
Earnings Per Share [Abstract]
Net loss per share	12. Net loss per share The following table presents the calculation of basic and diluted net loss per share attributable to common stockholders (in thousands, except share and per share amounts): Three Months Ended March 31, 2023 2022 Numerator: Net loss $ (44,544) $ (25,649) Denominator: Weighted-average shares used in computing net loss per share Basic and diluted 145,737,709 139,405,294 Net loss per share Basic and diluted $ (0.31) $ (0.18) The following potentially dilutive securities were excluded from the computation of diluted net loss per share calculations, because the impact of including them would have been anti-dilutive: Three Months Ended March 31, 2023 2022 Stock options 9,925,732 19,703,879 RSUs, PSUs, and restricted stock 17,431,152 4,168,525 Contingently issuable shares under ESPP 550,259 440,920 Total potentially dilutive securities 27,907,143 24,313,324

Segment and geographic informat

Segment and geographic information	3 Months Ended
	Mar. 31, 2023
Segment Reporting [Abstract]
Segment and geographic information	13. Segment and geographic information The Company’s Chief Executive Officer is its CODM. The CODM reviews separate financial information presented for the Company’s two segments, Enterprise and Consumer, in order to allocate resources and evaluate the Company’s financial performance. Financial information for each reportable segment was as follows (in thousands): Three Months Ended March 31, 2023 2022 Revenue Enterprise $ 95,242 $ 64,911 Consumer 81,188 87,312 Total revenue 176,430 152,223 Segment cost of revenue Enterprise 32,867 22,163 Consumer 37,496 39,797 Total segment cost of revenue 70,363 61,960 Segment gross profit Enterprise 62,375 42,748 Consumer 43,692 47,515 Total segment gross profit 106,067 90,263 Reconciliation of segment gross profit to gross profit Amortization of capitalized software 3,903 2,724 Amortization of intangible assets 725 725 Depreciation 117 189 Stock-based compensation 1,593 840 Total reconciling items 6,338 4,478 Total gross profit $ 99,729 $ 85,785 Geographic information Revenue : The following table summarizes the revenue by region based on the billing address of the Company’s customers (in thousands): Three Months Ended March 31, 2023 2022 North America $ 71,707 $ 60,588 Europe, Middle East, Africa 54,551 47,725 Asia Pacific 38,159 33,188 Latin America 12,013 10,722 Total revenue $ 176,430 $ 152,223 No single country other than the United States represented 10% or more of the Company’s total revenue du ring the three months ended March 31, 2023 or 2022. Long-lived assets : The following table presents the Company’s long-lived assets, which consist of tangible property and equipment, net of depreciation, and operating lease ROU assets, by geographic region (in thousands): March 31, December 31, 2023 2022 North America $ 11,083 $ 12,782 Rest of world 4,933 5,556 Total long-lived assets $ 16,016 $ 18,338

Restructuring charges

Restructuring charges	3 Months Ended
	Mar. 31, 2023
Restructuring and Related Activities [Abstract]
Restructuring charges	14. Restructuring charges On February 13, 2023, the Company communicated to its employees that in response to current macroeconomic conditions and to further streamline its operations and cost structure, it would reduce its global workforce by approximately 10%. As a result, the Company recognized total restructuring charges of $10.1 million in the first quarter of 2023, primarily consisting of $8.9 million of personnel expenses such as salaries and wages, one-time severance payments, and other benefits. The Company also recognized $1.2 million of stock-based compensation expense on the communication date, resulting from impacted employees having no future substantive service requirement but continuing to vest into their equity awards during legally required retention periods as well as certain modifications to enable additional vesting after impacted employees’ termination dates. The Company expects the restructuring to be complete by the end of the third quarter of 2023. Restructuring charges are presented as separate operating expenses within the Company’s condensed consolidated statements of operations. The following table summarizes the activity related to the restructuring liability recorded in accrued compensation and benefits in the accompanying condensed consolidated balance sheets (in thousands): Beginning balance— January 1, 2023 $ — Restructuring charges 8,920 Settlements (4,376) Ending balance— March 31, 2023 $ 4,544

Summary of significant accoun_2

Summary of significant accounting policies (Policies)	3 Months Ended
	Mar. 31, 2023
Accounting Policies [Abstract]
Basis of consolidation and presentation	Basis of consolidation and presentation —
Segment information	Segment information — On March 1, 2023, Greg Brown became the Company’s new Chief Executive Officer and chief operating decision maker (“CODM”). The Company defines its segments as those operations the CODM regularly reviews to allocate resources and assess performance. For the three months ended March 31, 2023 and 2022, the Company operated under two operating and reportable segments: Enterprise and Consumer. The Company continually monitors and reviews its segment reporting structure in accordance with Accounting Standards Codification (“ASC”) Topic 280, Segment Reporting, to determine whether any changes have occurred that would impact its reportable segments. For further information on the Com pany’s segment reporting, see Note 13 – Segment and geographic information.
Use of estimates	Use of estimates — The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the condensed consolidated financial statements and the results of operations during the reporting periods. Significant estimates and assumptions reflected in the condensed consolidated financial statements include, but are not limited to, allowance for credit losses, capitalization of internally developed software and ass ociated useful lives, stock-based compensation, determination of the income tax valuation allowance and the potential outcome of uncertain tax positions, estimated instructor withholding tax obligations, estimated service period for consumer single course purchases, the period of benefit for deferred commissions, t he fair value and associated useful lives of intangible assets and goodwill acquired via business combinations, and the valuation of privately-held strategic investments, including impairments. Management periodically evaluates such estimates and assumptions for continued reasonableness. Actual results may ultimately differ from management’s estimates and such differences could be material to the Company’s financial position and results of operations.
Concentration of credit risk	Concentration of credit risk — Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents, marketable securities, restricted cash, and accounts receivable. For cash and restricted cash, the Company is exposed to credit risk in the event of default by the financial institutions to the extent the amounts recorded on the accompanying condensed consolidated balance sheets are in excess of federal insurance limits. The Company’s investments, classified as cash equivalents and marketable securities, consist of high-credit-quality instruments and fixed-income securities.
Stock-based compensation	Stock-based compensation — The Company accounts for its stock-based compensation pursuant to ASC Topic 718, Compensation-Stock Compensation. The Company granted performance-based restricted stock units (“PSUs”) in the first quarter of 2023, which vest based on the achievement of predefined corporate performance metrics and are subject to ongoing service conditions. The Company determines the fair value of PSUs based on the fair value of the Company’s common stock on the date of grant. Because PSUs have both performance and service-based vesting conditions, the Company separately attributes stock-based compensation expense for each vesting tranche of the award over their requisite service periods.
Accounts receivable, net	Accounts receivable, net — Accounts receivable primarily represent amounts owed to the Company for Enterprise subscriptions. Also included in accounts receivable are amounts due from payment processors or mobile application store partners that settle over a period longer than five business days. Accounts receivable balances are recorded at the invoiced amount and are non-interest-bearing. Accounts receivable is presented net of allowance for credit losses in the accompanying condensed consolidated balance sheets. The Company maintains an allowance based upon expected credit losses of outstanding receivables. Management derives its estimate using a variety of factors, including historical collection and loss patterns; the current aging of receivables; geographic and other customer-specific credit risk factors; and reasonable and supportable forecasts of future economic conditions which inform adjustments to historical loss patterns. The provision for expected credit losses is recorded in general and administrative expenses in the accompanying condensed consolidated statements of operations. Accounts receivable deemed to be uncollectible are written off, net of expected or actual recoveries.
Self-insurance	Self-insurance —
Recently Adopted Accounting Pronouncements	Recently Adopted Accounting Pronouncements Recently Issued Accounting Pronouncements Not Yet Adopted

Summary of significant accoun_3

Summary of significant accounting policies (Tables)	3 Months Ended
	Mar. 31, 2023
Accounting Policies [Abstract]
Summary of Allowance for Credit Losses	Balance at Beginning of Period Charged to Expenses Charges Utilized/Written-off, Net of Recoveries Balance at End of Period Allowance for credit losses (in thousands) Three Months Ended March 31, 2023 $ 1,528 $ 301 $ (213) $ 1,616 Three Months Ended March 31, 2022 $ 678 $ 110 $ (110) $ 678

Revenue recognition (Tables)

Revenue recognition (Tables)	3 Months Ended
	Mar. 31, 2023
Revenue from Contract with Customer [Abstract]
Summary of Deferred Revenue Balances by Reportable Segment	The below table presents a summary of deferred revenue balances by reportable segment (in thousands): March 31, December 31, December 31, 2023 2022 2021 Deferred revenue: Enterprise $ 221,157 $ 219,030 $ 148,966 Consumer 59,241 59,249 61,588 Total deferred revenue $ 280,398 $ 278,279 $ 210,554
Summary of Deferred Contract Costs	The following table represents a rollforward of the Company’s deferred contract costs (in thousands): Balance at Beginning of Period Additions Amortization Expense Balance at End of Period Three Months Ended March 31, 2023 $ 65,645 $ 17,302 $ (10,508) $ 72,439 Three Months Ended March 31, 2022 $ 44,545 $ 13,038 $ (6,582) $ 51,001

Investments and fair value me_2

Investments and fair value measurements (Tables)	3 Months Ended
	Mar. 31, 2023
Fair Value Disclosures [Abstract]
Summary of Investments on Condensed Consolidated Balance Sheets	The Company’s assets and liabilities that are measured at fair value on a recurring or nonrecurring basis within the fair value hierarchy are as follows (in thousands): As of March 31, 2023 Level 1 Level 2 Level 3 Cash equivalents: Money market funds $ 237,819 $ — $ — Marketable securities: U.S. government securities $ — $ 169,613 $ — Non-current assets: Strategic investments $ — $ — $ 12,104 Current liabilities— accrued compensation and benefits: Cash settled stock appreciation rights $ — $ — $ 243 Non-current liabilities: Cash settled stock appreciation rights $ — $ — $ 21 As of December 31, 2022 Level 1 Level 2 Level 3 Cash equivalents: Money market funds $ 130,377 $ — $ — U.S. government securities — 48,900 — Total cash equivalents $ 130,377 $ 48,900 $ — Marketable securities: U.S. government securities $ — $ 151,687 $ — Non-current assets: Strategic investments $ — $ — $ 12,104 Non-current liabilities: Cash settled stock appreciation rights $ — $ — $ 462
Summary of Investments on Condensed Consolidated Balance Sheets	The Company’s assets and liabilities that are measured at fair value on a recurring or nonrecurring basis within the fair value hierarchy are as follows (in thousands): As of March 31, 2023 Level 1 Level 2 Level 3 Cash equivalents: Money market funds $ 237,819 $ — $ — Marketable securities: U.S. government securities $ — $ 169,613 $ — Non-current assets: Strategic investments $ — $ — $ 12,104 Current liabilities— accrued compensation and benefits: Cash settled stock appreciation rights $ — $ — $ 243 Non-current liabilities: Cash settled stock appreciation rights $ — $ — $ 21 As of December 31, 2022 Level 1 Level 2 Level 3 Cash equivalents: Money market funds $ 130,377 $ — $ — U.S. government securities — 48,900 — Total cash equivalents $ 130,377 $ 48,900 $ — Marketable securities: U.S. government securities $ — $ 151,687 $ — Non-current assets: Strategic investments $ — $ — $ 12,104 Non-current liabilities: Cash settled stock appreciation rights $ — $ — $ 462
Summary of the Changes in the Fair Value of Level 3 Financial Instruments	A summary of the changes in the fair value of Level 3 financial instruments, of which remeasurement of SARs are recognized in the condensed consolidated statements of operations, is as follows (in thousands): Stock Appreciation Rights Strategic Investments Balance— December 31, 2022 $ 462 $ 12,104 Vesting and remeasurement of SARs (198) — Balance— March 31, 2023 $ 264 $ 12,104 Balance— December 31, 2021 $ 818 $ 10,000 Vesting and remeasurement of SARs, net (310) — Purchases of strategic investments — 5,000 Balance— March 31, 2022 $ 508 $ 15,000
Summary of the Changes in the Fair Value of Level 3 Financial Instruments	A summary of the changes in the fair value of Level 3 financial instruments, of which remeasurement of SARs are recognized in the condensed consolidated statements of operations, is as follows (in thousands): Stock Appreciation Rights Strategic Investments Balance— December 31, 2022 $ 462 $ 12,104 Vesting and remeasurement of SARs (198) — Balance— March 31, 2023 $ 264 $ 12,104 Balance— December 31, 2021 $ 818 $ 10,000 Vesting and remeasurement of SARs, net (310) — Purchases of strategic investments — 5,000 Balance— March 31, 2022 $ 508 $ 15,000

Consolidated balance sheet co_2

Consolidated balance sheet components (Tables)	3 Months Ended
	Mar. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Summary of Cash, Cash Equivalents, and Marketable Securities	The amortized cost, unrealized gains and losses, and estimated fair value of cash, cash equivalents, and marketable securities consisted of the following (in thousands): As of March 31, 2023 Amortized Cost Unrealized Gains Unrealized Losses Fair Value Cash and cash equivalents: Cash $ 37,814 $ — $ — $ 37,814 Money market funds 237,819 — — 237,819 Total cash and cash equivalents 275,633 — — 275,633 Marketable securities: U.S. government securities 169,677 40 (104) 169,613 Total cash, cash equivalents, and marketable securities $ 445,310 $ 40 $ (104) $ 445,246 As of December 31, 2022 Amortized Cost Unrealized Gains Unrealized Losses Fair Value Cash and cash equivalents: Cash $ 134,408 $ — $ — $ 134,408 Money market funds 130,377 — — 130,377 U.S. government securities 48,899 4 (3) 48,900 Total cash and cash equivalents 313,684 4 (3) 313,685 Marketable securities: U.S. government securities 151,900 30 (243) 151,687 Total cash, cash equivalents, and marketable securities $ 465,584 $ 34 $ (246) $ 465,372 Cash equivalents and marketable securities in an unrealized loss position consisted of the following (in thousands): March 31, 2023 December 31, 2022 Fair Value Gross Unrealized Losses Fair Value Gross Unrealized Losses Cash equivalents: U.S. government securities $ — $ — $ 24,960 $ (3) Marketable securities: U.S. government securities 37,102 (104) 59,057 (243) Total securities in an unrealized loss position $ 37,102 $ (104) $ 84,017 $ (246)
Summary of Property and Equipment, Net	Property and equipment, net consisted of the following (in thousands): March 31, December 31, 2023 2022 Computers and equipment $ 7,756 $ 7,820 Furniture and fixtures 4,678 4,870 Purchased software 383 383 Leasehold improvements 19,017 19,109 Construction in progress 8 — Total property and equipment 31,842 32,182 Less accumulated depreciation and amortization (25,636) (25,170) Property and equipment, net $ 6,206 $ 7,012
Summary of Capitalized Computer Software	Capitalized software, net consisted of the following (in thousands): March 31, December 31, 2023 2022 Capitalized software $ 69,284 $ 63,748 Less accumulated amortization (40,239) (36,336) Capitalized software, net $ 29,045 $ 27,412
Summary of Expected Amortization Expense	As of March 31, 2023, expected amortization expense for capitalized software over the remaining asset lives was as follows (in thousands): Remainder of 2023 $ 11,583 2024 11,496 2025 5,630 2026 336 Total expected amortization $ 29,045 The expected future amortization expense for intangible assets as of March 31, 2023 was as follows (in thousands): Remainder of 2023 $ 3,041 2024 2,795 2025 917 2026 917 2027 594 Total expected amortization $ 8,264
Summary of Intangible Assets Acquired through Business Combination	Intangible assets, net and goodwill— As of March 31, 2023, intangible assets, net acquired as part of the CorpU business combination were as follows (in thousands): Estimated Useful Lives Intangible Assets, Gross Accumulated Amortization Intangible Assets, Net Customer relationships 6 years $ 5,500 $ (1,469) $ 4,031 Vendor relationships 3 years 4,500 (2,403) 2,097 Developed technology 3 years 4,200 (2,243) 1,957 Tradename 2 years 900 (721) 179 Total $ 15,100 $ (6,836) $ 8,264 As of December 31, 2022, intangible assets, net acquired as part of the CorpU business combination were as follows (in thousands): Estimated Useful Lives Intangible Assets, Gross Accumulated Amortization Intangible Assets, Net Customer relationships 6 years $ 5,500 $ (1,239) $ 4,261 Vendor relationships 3 years 4,500 (2,028) 2,472 Developed technology 3 years 4,200 (1,893) 2,307 Tradename 2 years 900 (609) 291 Total $ 15,100 $ (5,769) $ 9,331

Leases (Tables)

Leases (Tables)	3 Months Ended
	Mar. 31, 2023
Leases [Abstract]
Summary of Information Pertaining to Operating Leases	The Company recognized the following amounts related to its operating leases in its condensed consolidated statements of operations and cash flows (in thousands): Three Months Ended March 31, 2023 2022 Operating lease costs $ 1,670 $ 1,701 Variable lease costs $ 314 $ 204 Cash paid for operating leases $ 1,923 $ 1,151
Summary of Future Minimum Lease Payments	Future minimum lease payments under noncancellable operating leases with initial lease terms in excess of one year as of March 31, 2023, were as follows (in thousands): 2023 $ 5,279 2024 5,790 2025 809 2026 410 Gross lease payments 12,288 Less imputed interest (458) Present value of operating lease liabilities $ 11,830

Accrued expenses and other cu_2

Accrued expenses and other current liabilities (Tables)	3 Months Ended
	Mar. 31, 2023
Payables and Accruals [Abstract]
Summary of Accrued Expenses and Other Current Liabilities	Accrued expenses and other current liabilities consist of the following (in thousands): March 31, December 31, 2023 2022 Accrued expenses $ 7,262 $ 8,494 Indirect tax reserves 4,158 6,627 Indirect tax payables 7,968 9,137 Other current liabilities 7,032 6,989 Accrued expenses and other current liabilities $ 26,420 $ 31,247
Summary of Changes to the Withholding Tax Reserve	Changes to the instructor withholding tax reserve are as follows (in thousands): Three Months Ended March 31, 2023 2022 Balance, beginning of period $ 2,528 $ 17,036 Amounts charged to (released from) expense 44 (1,343) Net payments and settlements — — Balance, end of period $ 2,572 $ 15,693

Stockholders' equity (Tables)

Stockholders' equity (Tables)	3 Months Ended
	Mar. 31, 2023
Share-Based Payment Arrangement [Abstract]
Summary of Common Stock Reserved for Future Issuance	As of March 31, 2023 and December 31, 2022, the following shares of common stock were available for future issuance: March 31, December 31, 2023 2022 2010 Equity Incentive Plan: Stock options outstanding 9,925,732 10,333,771 2021 Equity Incentive Plan: RSUs outstanding and PSUs (1) 17,713,184 16,178,101 Shares available for future issuance under: 2021 Equity Incentive Plan 7,324,533 2,814,126 2021 Employee Stock Purchase Plan 3,379,715 1,929,578 Total shares of common stock reserved 38,343,164 31,255,576 (1) The number of PSUs reserved for issuance is based on the maximum achievement of the corporate performance metric.
Summary of Option Activity	The following is a summary of activity for stock options having only service-based vesting conditions under the Equity Incentive Plans: Options Outstanding Weighted Average Exercise Price Weighted Average Remaining Contractual Term Aggregate Intrinsic Value Balance - December 31, 2022 10,283,771 $ 4.18 6.38 $ 66,234 Granted — — Exercised (355,516) 4.10 Canceled (52,523) 11.28 Balance - March 31, 2023 9,875,732 $ 4.15 3.06 $ 47,212 Vested & expected to vest as of March 31, 2023 9,875,732 $ 4.15 3.06 $ 47,212 Exercisable as of March 31, 2023 8,973,521 $ 3.92 2.89 $ 44,616
Summary of Stock Appreciation Rights	The following is a summary of activity for SARs under the Equity Incentive Plans: SARs Outstanding Weighted Average Exercise Price Weighted Average Remaining Contractual Term Aggregate Intrinsic Value Balance - December 31, 2022 81,770 $ 5.44 6.90 $ 418 Granted — — Exercised — — Canceled (9,289) 6.58 Balance - March 31, 2023 72,481 $ 5.29 0.57 $ 257 Vested & expected to vest as of March 31, 2023 72,481 $ 5.29 0.57 $ 257 Exercisable as of March 31, 2023 71,706 $ 5.28 0.50 $ 254
Summary of Restricted Stock Unit Activity	A summary of RSU and PSU activity under the 2021 Plan is as follows: RSUs Outstanding Weighted Average Grant Date Fair Value PSUs Outstanding Weighted Average Grant Date Fair Value Unvested - December 31, 2022 16,178,101 $ 17.37 — $ — Granted 2,290,999 $ 9.84 645,833 $ 8.89 Released (1,257,722) $ 17.91 — $ — Canceled (466,926) $ 15.48 — $ — Unvested - March 31, 2023 16,744,452 $ 16.35 645,833 $ 8.89
Summary of Performance-Based Options	A summary of RSU and PSU activity under the 2021 Plan is as follows: RSUs Outstanding Weighted Average Grant Date Fair Value PSUs Outstanding Weighted Average Grant Date Fair Value Unvested - December 31, 2022 16,178,101 $ 17.37 — $ — Granted 2,290,999 $ 9.84 645,833 $ 8.89 Released (1,257,722) $ 17.91 — $ — Canceled (466,926) $ 15.48 — $ — Unvested - March 31, 2023 16,744,452 $ 16.35 645,833 $ 8.89
Summary of Stock-Based Compensation Expense	Total stock-based compensation expense included in the condensed consolidated statements of operations was as follows (in thousands): Three Months Ended March 31, 2023 2022 Cost of revenue $ 1,593 $ 840 Sales and marketing 7,277 4,137 Research and development 6,294 3,334 General and administrative 9,911 5,031 Restructuring charges 1,208 — Total stock-based compensation expense $ 26,283 $ 13,342

Net loss per share (Tables)

Net loss per share (Tables)	3 Months Ended
	Mar. 31, 2023
Earnings Per Share [Abstract]
Summary of Net Earnings (Loss) per Share	The following table presents the calculation of basic and diluted net loss per share attributable to common stockholders (in thousands, except share and per share amounts): Three Months Ended March 31, 2023 2022 Numerator: Net loss $ (44,544) $ (25,649) Denominator: Weighted-average shares used in computing net loss per share Basic and diluted 145,737,709 139,405,294 Net loss per share Basic and diluted $ (0.31) $ (0.18)
Summary of Potentially Dilutive Securities Excluded from Computation of Diluted Net Loss per Share	The following potentially dilutive securities were excluded from the computation of diluted net loss per share calculations, because the impact of including them would have been anti-dilutive: Three Months Ended March 31, 2023 2022 Stock options 9,925,732 19,703,879 RSUs, PSUs, and restricted stock 17,431,152 4,168,525 Contingently issuable shares under ESPP 550,259 440,920 Total potentially dilutive securities 27,907,143 24,313,324

Segment and geographic inform_2

Segment and geographic information (Tables)	3 Months Ended
	Mar. 31, 2023
Segment Reporting [Abstract]
Summary of Financial Information by Each Reportable Segment	Financial information for each reportable segment was as follows (in thousands): Three Months Ended March 31, 2023 2022 Revenue Enterprise $ 95,242 $ 64,911 Consumer 81,188 87,312 Total revenue 176,430 152,223 Segment cost of revenue Enterprise 32,867 22,163 Consumer 37,496 39,797 Total segment cost of revenue 70,363 61,960 Segment gross profit Enterprise 62,375 42,748 Consumer 43,692 47,515 Total segment gross profit 106,067 90,263 Reconciliation of segment gross profit to gross profit Amortization of capitalized software 3,903 2,724 Amortization of intangible assets 725 725 Depreciation 117 189 Stock-based compensation 1,593 840 Total reconciling items 6,338 4,478 Total gross profit $ 99,729 $ 85,785
Summary of Revenue by Region	The following table summarizes the revenue by region based on the billing address of the Company’s customers (in thousands): Three Months Ended March 31, 2023 2022 North America $ 71,707 $ 60,588 Europe, Middle East, Africa 54,551 47,725 Asia Pacific 38,159 33,188 Latin America 12,013 10,722 Total revenue $ 176,430 $ 152,223
Summary of Long-lived Assets by Region	The following table presents the Company’s long-lived assets, which consist of tangible property and equipment, net of depreciation, and operating lease ROU assets, by geographic region (in thousands): March 31, December 31, 2023 2022 North America $ 11,083 $ 12,782 Rest of world 4,933 5,556 Total long-lived assets $ 16,016 $ 18,338

Restructuring charges (Tables)

Restructuring charges (Tables)	3 Months Ended
	Mar. 31, 2023
Restructuring and Related Activities [Abstract]
Summary of Restructuring Charges	The following table summarizes the activity related to the restructuring liability recorded in accrued compensation and benefits in the accompanying condensed consolidated balance sheets (in thousands): Beginning balance— January 1, 2023 $ — Restructuring charges 8,920 Settlements (4,376) Ending balance— March 31, 2023 $ 4,544

Summary of significant accoun_4

Summary of significant accounting policies - Narrative (Details) $ in Millions	3 Months Ended
	Mar. 31, 2023 USD ($) segment	Mar. 31, 2022 segment
Disaggregation of Revenue [Line Items]
Number of operating segments	2	2
Number of reportable segments	2	2
Self insurance | $	$ 1
Customer Concentration Risk | Accounts Receivable | One Customer
Disaggregation of Revenue [Line Items]
Concentration risk, percentage	10%

Summary of significant accoun_5

Summary of significant accounting policies - Summary of Allowance for Credit Losses (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Accounts Receivable, Allowance for Credit Loss [Roll Forward]
Balance at Beginning of Period	$ 1,528	$ 678
Charged to Expenses	301	110
Charges Utilized/Written-off, Net of Recoveries	(213)	(110)
Balance at End of Period	$ 1,616	$ 678

Revenue recognition - Narrative

Revenue recognition - Narrative (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Contract with customer, liability, revenue recognized	$ 134.6	$ 111.4
Remaining performance obligation, amount	$ 502.3
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-04-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Remaining performance obligation, percentage	70%
Revenue, remaining performance obligation, period	12 months
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-04-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Remaining performance obligation, percentage	31%
Revenue, remaining performance obligation, period

Revenue recognition - Summary o

Revenue recognition - Summary of Deferred Revenue Balances by Reportable Segment (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Disaggregation of Revenue [Line Items]
Total deferred revenue	$ 280,398	$ 278,279	$ 210,554
Enterprise
Disaggregation of Revenue [Line Items]
Total deferred revenue	221,157	219,030	148,966
Consumer
Disaggregation of Revenue [Line Items]
Total deferred revenue	$ 59,241	$ 59,249	$ 61,588

Revenue recognition - Summary_2

Revenue recognition - Summary of Deferred Contract Costs (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Deferred contract costs [Roll Forward]
Balance at Beginning of Period	$ 65,645	$ 44,545
Additions	17,302	13,038
Amortization Expense	(10,508)	(6,582)
Balance at End of Period	$ 72,439	$ 51,001

Investments and fair value me_3

Investments and fair value measurements - Summary of Investments on Condensed Consolidated Balance Sheets (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Assets
Marketable securities	$ 445,246	$ 465,372
Strategic investments	12,104	12,104
Level 1
Assets
Cash equivalents		130,377
Strategic investments	0	0
Current liabilities— accrued compensation and benefits:
Cash settled stock appreciation rights	0
Non-current liabilities:
Cash settled stock appreciation rights	0	0
Level 1 | U.S. government securities
Assets
Cash equivalents		0
Marketable securities	0	0
Level 1 | Money market funds
Assets
Cash equivalents	237,819	130,377
Level 2
Assets
Cash equivalents		48,900
Strategic investments	0	0
Current liabilities— accrued compensation and benefits:
Cash settled stock appreciation rights	0
Non-current liabilities:
Cash settled stock appreciation rights	0	0
Level 2 | U.S. government securities
Assets
Cash equivalents		48,900
Marketable securities	169,613	151,687
Level 2 | Money market funds
Assets
Cash equivalents	0	0
Level 3
Assets
Cash equivalents		0
Strategic investments	12,104	12,104
Current liabilities— accrued compensation and benefits:
Cash settled stock appreciation rights	243
Non-current liabilities:
Cash settled stock appreciation rights	21	462
Level 3 | U.S. government securities
Assets
Cash equivalents		0
Marketable securities	0	0
Level 3 | Money market funds
Assets
Cash equivalents	$ 0	$ 0

Investments and fair value me_4

Investments and fair value measurements - Summary of the Changes in the Fair Value of Level 3 Financial Instruments (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Preferred Stock
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Vesting and remeasurement of SARs	$ 0	$ 0
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning balance	12,104	10,000
Purchases of strategic investments		5,000
Ending balance	12,104	15,000
Stock Appreciation Rights
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning balance	462	818
Vesting and remeasurement of SARs	(198)	(310)
Ending balance	$ 264	508
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Purchases of strategic investments		$ 0

Investments and fair value me_5

Investments and fair value measurements - Narrative (Details)	3 Months Ended
	Mar. 31, 2023 USD ($)
Fair Value Disclosures [Abstract]
Impairment of strategic investment	$ 0
Strategic investment’s cost basis	15,000,000
Carrying value	12,100,000
Cumulative impairment charges	$ 2,900,000

Consolidated balance sheet co_3

Consolidated balance sheet components - Summary of Cash, Cash Equivalents, and Marketable Securities (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Cash and Cash Equivalents [Line Items]
Amortized Cost	$ 445,310	$ 465,584
Unrealized Gains	40	34
Unrealized Losses	(104)	(246)
Fair Value	445,246	465,372
Unrealized Loss Position, Fair Value	37,102	84,017
Cash and Cash Equivalents
Cash and Cash Equivalents [Line Items]
Amortized Cost	275,633	313,684
Unrealized Gains	0	4
Unrealized Losses	0	(3)
Fair Value	275,633	313,685
Unrealized Loss Position, Fair Value	0	24,960
Cash and Cash Equivalents | Cash
Cash and Cash Equivalents [Line Items]
Amortized Cost	37,814	134,408
Unrealized Gains	0	0
Unrealized Losses	0	0
Fair Value	37,814	134,408
Cash and Cash Equivalents | Money market funds
Cash and Cash Equivalents [Line Items]
Amortized Cost	237,819	130,377
Unrealized Gains	0	0
Unrealized Losses	0	0
Fair Value	237,819	130,377
Cash and Cash Equivalents | U.S. government securities
Cash and Cash Equivalents [Line Items]
Amortized Cost		48,899
Unrealized Gains		4
Unrealized Losses		(3)
Fair Value		48,900
Marketable Securities | U.S. government securities
Cash and Cash Equivalents [Line Items]
Amortized Cost	169,677	151,900
Unrealized Gains	40	30
Unrealized Losses	(104)	(243)
Fair Value	169,613	151,687
Unrealized Loss Position, Fair Value	$ 37,102	$ 59,057

Consolidated balance sheet co_4

Consolidated balance sheet components - Narrative (Details) $ in Thousands	3 Months Ended
	Mar. 31, 2023 USD ($) security	Mar. 31, 2022 USD ($)	Dec. 31, 2022 USD ($)	Aug. 24, 2021 USD ($)
Acquired Finite-Lived Intangible Assets [Line Items]
Realized gains and losses reclassified from accumulated other comprehensive loss to other income (expense), net	$ 0
Number of continuous unrealized loss position for twelve months or longer | security	0
Depreciation	$ 800	$ 1,200
Amortization of capitalized software	3,900	2,700
Amortization of intangible assets	1,100	$ 1,100
Goodwill	$ 12,646		$ 12,646
CorpU
Acquired Finite-Lived Intangible Assets [Line Items]
Goodwill				$ 12,600

Consolidated balance sheet co_5

Consolidated balance sheet components - Summary of Property and Equipment, Net (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Property, Plant and Equipment [Line Items]
Total property and equipment	$ 31,842	$ 32,182
Less accumulated depreciation and amortization	(25,636)	(25,170)
Property and equipment, net	6,206	7,012
Computers and equipment
Property, Plant and Equipment [Line Items]
Total property and equipment	7,756	7,820
Furniture and fixtures
Property, Plant and Equipment [Line Items]
Total property and equipment	4,678	4,870
Purchased software
Property, Plant and Equipment [Line Items]
Total property and equipment	383	383
Leasehold improvements
Property, Plant and Equipment [Line Items]
Total property and equipment	19,017	19,109
Construction in progress
Property, Plant and Equipment [Line Items]
Total property and equipment	$ 8	$ 0

Consolidated balance sheet co_6

Consolidated balance sheet components - Summary of Capitalized Computer Software (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Capitalized software	$ 69,284	$ 63,748
Less accumulated amortization	(40,239)	(36,336)
Total expected amortization	$ 29,045	$ 27,412

Consolidated balance sheet co_7

Consolidated balance sheet components - Summary of Expected Amortization Expense (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Remainder of 2023	$ 11,583
2024	11,496
2025	5,630
2026	336
Total expected amortization	$ 29,045	$ 27,412

Consolidated balance sheet co_8

Consolidated balance sheet components - Summary of Intangible Assets Acquired through Business Combination (Details) - USD ($) $ in Thousands	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Acquired Finite-Lived Intangible Assets [Line Items]
Intangible Assets, Gross	$ 15,100	$ 15,100
Accumulated Amortization	(6,836)	(5,769)
Intangible Assets, Net	$ 8,264	$ 9,331
Customer relationships
Acquired Finite-Lived Intangible Assets [Line Items]
Estimated Useful Lives	6 years	6 years
Intangible Assets, Gross	$ 5,500	$ 5,500
Accumulated Amortization	(1,469)	(1,239)
Intangible Assets, Net	$ 4,031	$ 4,261
Vendor relationships
Acquired Finite-Lived Intangible Assets [Line Items]
Estimated Useful Lives	3 years	3 years
Intangible Assets, Gross	$ 4,500	$ 4,500
Accumulated Amortization	(2,403)	(2,028)
Intangible Assets, Net	$ 2,097	$ 2,472
Developed technology
Acquired Finite-Lived Intangible Assets [Line Items]
Estimated Useful Lives	3 years	3 years
Intangible Assets, Gross	$ 4,200	$ 4,200
Accumulated Amortization	(2,243)	(1,893)
Intangible Assets, Net	$ 1,957	$ 2,307
Tradename
Acquired Finite-Lived Intangible Assets [Line Items]
Estimated Useful Lives	2 years	2 years
Intangible Assets, Gross	$ 900	$ 900
Accumulated Amortization	(721)	(609)
Intangible Assets, Net	$ 179	$ 291

Consolidated balance sheet co_9

Consolidated balance sheet components - Summary of Expected Amortization Expense (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Remainder of 2023	$ 3,041
2024	2,795
2025	917
2026	917
2027	594
Total expected amortization	$ 8,264	$ 9,331

Leases - Summary of Information

Leases - Summary of Information Pertaining to Operating Leases (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Leases [Abstract]
Operating lease costs	$ 1,670	$ 1,701
Variable lease costs	314	204
Cash paid for operating leases	$ 1,923	$ 1,151

Leases - Summary of Future Mini

Leases - Summary of Future Minimum Lease Payments (Details) $ in Thousands	Mar. 31, 2023 USD ($)
Leases [Abstract]
2023	$ 5,279
2024	5,790
2025	809
2026	410
Gross lease payments	12,288
Less imputed interest	(458)
Present value of operating lease liabilities	$ 11,830

Accrued expenses and other cu_3

Accrued expenses and other current liabilities - Summary of Accrued Expenses and Other Current Liabilities (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Payables and Accruals [Abstract]
Accrued expenses	$ 7,262	$ 8,494
Indirect tax reserves	4,158	6,627
Indirect tax payables	7,968	9,137
Other current liabilities	7,032	6,989
Accrued expenses and other current liabilities	$ 26,420	$ 31,247

Accrued expenses and other cu_4

Accrued expenses and other current liabilities - Changes to Withholding Tax Reserve (Details) - Historical Tax Withholding Possible Loss - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Loss Contingency Accrual [Roll Forward]
Balance, beginning of period	$ 2,528	$ 17,036
Amounts charged to (released from) expense	44	(1,343)
Net payments and settlements	0	0
Balance, end of period	$ 2,572	$ 15,693

Commitments and contingencies -

Commitments and contingencies - Narrative (Details) $ in Millions	Mar. 31, 2023 USD ($)
Commitments and Contingencies Disclosure [Abstract]
Future minimum payments	$ 55.4

Income taxes - Narrative (Detai

Income taxes - Narrative (Details)	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Income Tax Disclosure [Abstract]
Effective income tax rate, percent	(2.43%)	(1.30%)

Related party transactions (Det

Related party transactions (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022
Related Party Transaction [Line Items]
Accounts receivable, related parties	$ 0		$ 0.4
Naspers
Related Party Transaction [Line Items]
Ownership percentage	5%
Affiliated Entity | Naspers Ltd. and Other Entity
Related Party Transaction [Line Items]
Revenue from related parties	$ 0.3	$ 0.4
Accounts receivable, related parties	0.1		$ 0.1
Affiliated Entity | Certain Vendors
Related Party Transaction [Line Items]
General and administrative expenses, related party	0.2	0.2
Board of Directors | Enterprise Subscription Offering
Related Party Transaction [Line Items]
Revenue from related parties	$ 0.1	$ 0.1

Stockholders' equity - Narrativ

Stockholders' equity - Narrative (Details) $ / shares in Units, $ in Thousands			3 Months Ended
	Jan. 01, 2023 shares	Aug. 24, 2021 $ / shares shares	Mar. 31, 2023 USD ($) segment vote $ / shares shares	Mar. 31, 2022 USD ($) shares	Dec. 31, 2022 $ / shares shares	Oct. 29, 2021 shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Preferred stock, shares authorized (in shares)			50,000,000		50,000,000
Preferred stock, par value (in dollars per share) | $ / shares			$ 0.00001		$ 0.00001
Number of votes per common stock | vote			1
Unrecognized compensation costs, options | $			$ 2,200
Total shares of common stock reserved (in shares)			38,343,164		31,255,576
Stock-based compensation | $			$ 26,283	$ 13,342
Stock-based compensation capitalized as a software | $			2,300	$ 1,200
Tender Offer to Sell Common Stock to an Investor
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation | $			$ 3,100
Stock options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Contractual term (in years)			10 years
Award vesting period (in years)			4 years
Unrecognized compensation costs, period for recognition (in years)			9 months 18 days
Stock options outstanding (in shares)			9,925,732		10,333,771
Stock Appreciation Rights
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Contractual term (in years)			10 years
Award vesting period (in years)			4 years
Granted (in shares)			0	0
Restricted Stock Units (RSUs)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized compensation costs, period for recognition (in years)			3 years
Unrecognized compensation costs, excluding options | $			$ 221,000
Restricted stock issued for business combination, grant date fair value (in dollars per share) | $ / shares			$ 16.35		$ 17.37
Restricted Stock Units (RSUs) | Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period (in years)			3 years
Restricted Stock Units (RSUs) | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period (in years)			4 years
Performance-Based Awards
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized compensation costs, period for recognition (in years)			2 years 2 months 12 days
Corporate performance metric attainment percentage			1
Granted (in shares)			645,833
Number of shares right to receive (in shares)			1
Award vesting rights, percentage			75%
Unrecognized compensation costs, excluding options | $			$ 5,600
Stock options outstanding (in shares)			50,000
Restricted stock issued for business combination, grant date fair value (in dollars per share) | $ / shares			$ 8.89		$ 0
Performance-Based Awards | Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting rights, percentage			0%
Performance-Based Awards | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting rights, percentage			150%
Contingently issuable shares under ESPP
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized compensation costs, period for recognition (in years)			1 year 3 months 18 days
Unrecognized compensation costs, excluding options | $			$ 6,500
Total shares of common stock reserved (in shares)	1,450,137					2,800,000
Minimum annual increase in shares reserved for issuance			1%
Number of initial shares reserved | segment			3
Percent of outstanding shares			300%
Restricted stock | CorpU
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized compensation costs, period for recognition (in years)			1 year 4 months 24 days
Unrecognized compensation costs, excluding options | $			$ 1,000
Stock-based compensation | $			$ 200	$ 200
Restricted stock issued for business combination (in shares)		61,300
Restricted stock issued for business combination, grant date fair value (in dollars per share) | $ / shares		$ 34.14
2021 Stock incentive Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares reserved for future issuance (in shares)			13,800,000
Number of shares reserved for future issuance increased (in shares)	7,250,689
Annual percentage increase, term			0.05
Granted (in shares)			0
Stock options outstanding (in shares)			9,875,732		10,283,771
Exercisable, weighted average exercise price (in USD per share) | $ / shares			$ 3.92
Amended and Restated 2010 Equity Incentive Plan | Performance-Based Awards
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock options outstanding (in shares)			16,666

Stockholders' equity - Summary

Stockholders' equity - Summary of Common Stock Reserved for Future Issuance (Details) - shares	Mar. 31, 2023	Dec. 31, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total shares of common stock reserved (in shares)	38,343,164	31,255,576
Stock options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock options outstanding (in shares)	9,925,732	10,333,771
Restricted Stock Units RSU and Performance Shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
RSUs outstanding and PSUs (in shares)	17,713,184	16,178,101
2021 Equity Incentive Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock options available for future issuance (in shares)	7,324,533	2,814,126
2021 Employee Stock Purchase Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock options available for future issuance (in shares)	3,379,715	1,929,578

Stockholders' equity - Summar_2

Stockholders' equity - Summary of Stock Option Activity (Details) - 2021 Stock incentive Plan - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Options Outstanding
Outstanding, beginning balance (in shares)	10,283,771
Granted (in shares)	0
Exercised (in shares)	(355,516)
Canceled (in shares)	(52,523)
Outstanding, ending balance (in shares)	9,875,732	10,283,771
Vested & expected to vest, awards outstanding (in shares)	9,875,732
Exercisable, awards outstanding (in shares)	8,973,521
Weighted Average Exercise Price
Outstanding, beginning balance (in USD per share)	$ 4.18
Granted (in USD per share)	0
Exercised (in USD per share)	4.10
Canceled (in USD per share)	11.28
Outstanding, ending balance (in USD per share)	4.15	$ 4.18
Vested & expected to vest, weighted average exercise price (in USD per shares)	4.15
Exercisable, weighted average exercise price (in USD per share)	$ 3.92
Outstanding, weighted average remaining contractual term	3 years 21 days	6 years 4 months 17 days
Outstanding, aggregate intrinsic value	$ 47,212	$ 66,234
Vested & expected to vest, weighted average remaining contractual term	3 years 21 days
Vested & expected to vest, aggregate intrinsic value	$ 47,212
Exercisable, weighted average remaining contractual term	2 years 10 months 20 days
Exercisable, aggregate intrinsic value	$ 44,616

Stockholders' equity - Summar_3

Stockholders' equity - Summary of SARs Activity (Details) - Stock Appreciation Rights - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		12 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022
SARs Outstanding
Outstanding, beginning balance (in shares)	81,770
Granted (in shares)	0	0
Exercised (in shares)	0
Canceled (in shares)	(9,289)
Outstanding, ending balance (in shares)	72,481		81,770
Vested and expected to vest, SARs outstanding (in shares)	72,481
Exercisable, SARs outstanding (in shares)	71,706
Weighted Average Exercise Price
Outstanding, beginning balance (in USD per share)	$ 5.44
Granted (in USD per share)	0
Exercised (in USD per share)	0
Canceled (in USD per share)	6.58
Outstanding, ending balance (in USD per share)	5.29		$ 5.44
Vested and expected to vest, weighted average exercise price (in USD per shares)	5.29
Exercisable, weighted average exercise price (in USD per share)	$ 5.28
Outstanding, weighted average remaining contractual term	6 months 25 days		6 years 10 months 24 days
Outstanding, aggregate intrinsic value	$ 257		$ 418
Vested and expected to vest, weighted average remaining contractual term	6 months 25 days
Vested and expected to vest, aggregate intrinsic value	$ 257
Exercisable, weighted average remaining contractual term	6 months
Exercisable, aggregate intrinsic value	$ 254

Stockholders' equity - RSU Acti

Stockholders' equity - RSU Activity (Details)	3 Months Ended
	Mar. 31, 2023 $ / shares shares
Restricted Stock Units (RSUs)
RSUs Outstanding
Unvested beginning balance (in shares) | shares	16,178,101
Granted (in shares) | shares	2,290,999
Released (in shares) | shares	(1,257,722)
Canceled (in shares) | shares	(466,926)
Unvested ending balance (in shares) | shares	16,744,452
Weighted Average Grant Date Fair Value
Unvested beginning balance (in USD per share) | $ / shares	$ 17.37
Granted (in USD per share) | $ / shares	9.84
Released (in USD per share) | $ / shares	17.91
Canceled (in USD per share) | $ / shares	15.48
Unvested ending balance (in USD per share) | $ / shares	$ 16.35
Performance-Based Awards
RSUs Outstanding
Unvested beginning balance (in shares) | shares	0
Granted (in shares) | shares	645,833
Released (in shares) | shares	0
Canceled (in shares) | shares	0
Unvested ending balance (in shares) | shares	645,833
Weighted Average Grant Date Fair Value
Unvested beginning balance (in USD per share) | $ / shares	$ 0
Granted (in USD per share) | $ / shares	8.89
Released (in USD per share) | $ / shares	0
Canceled (in USD per share) | $ / shares	0
Unvested ending balance (in USD per share) | $ / shares	$ 8.89

Stockholders' equity - Stock-Ba

Stockholders' equity - Stock-Based Compensation Expense (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation	$ 26,283	$ 13,342
Cost of revenue
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation	1,593	840
Sales and marketing
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation	7,277	4,137
Research and development
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation	6,294	3,334
General and administrative
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation	9,911	5,031
Restructuring charges
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation	$ 1,208	$ 0

Net loss per share - Summary of

Net loss per share - Summary of Net Earnings (Loss) per Share (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Numerator:
Net loss	$ (44,544)	$ (25,649)
Net loss	$ (44,544)	$ (25,649)
Weighted-average shares used in computing net loss per share
Basic (in shares)	145,737,709	139,405,294
Diluted (in shares)	145,737,709	139,405,294
Net loss per share
Basic (in dollars per share)	$ (0.31)	$ (0.18)
Diluted (in dollars per share)	$ (0.31)	$ (0.18)

Net loss per share - Summary _2

Net loss per share - Summary of Potentially Dilutive Securities Excluded from Computation of Diluted Net Loss per Share (Details) - shares	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total potentially dilutive securities (in shares)	27,907,143	24,313,324
Stock options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total potentially dilutive securities (in shares)	9,925,732	19,703,879
RSUs, PSUs, and restricted stock
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total potentially dilutive securities (in shares)	17,431,152	4,168,525
Contingently issuable shares under ESPP
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total potentially dilutive securities (in shares)	550,259	440,920

Segment and geographic inform_3

Segment and geographic information - Narrative (Details) - segment	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Segment Reporting [Abstract]
Number of operating segments	2	2
Number of reportable segments	2	2

Segment and geographic inform_4

Segment and geographic information - Summary of Financial Information by Each Reportable Segment (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Segment Reporting Information [Line Items]
Revenue	$ 176,430	$ 152,223
Segment cost of revenue	76,701	66,438
Gross profit	99,729	85,785
Reconciliation of segment gross profit to gross profit
Amortization of capitalized software	3,900	2,700
Amortization of intangible assets	1,100	1,100
Depreciation	800	1,200
Stock-based compensation	26,283	13,342
Gross profit	99,729	85,785
Operating Segments
Segment Reporting Information [Line Items]
Revenue	176,430	152,223
Segment cost of revenue	70,363	61,960
Gross profit	106,067	90,263
Reconciliation of segment gross profit to gross profit
Gross profit	106,067	90,263
Segment Reconciling Items
Segment Reporting Information [Line Items]
Gross profit	6,338	4,478
Reconciliation of segment gross profit to gross profit
Amortization of capitalized software	3,903	2,724
Amortization of intangible assets	725	725
Depreciation	117	189
Stock-based compensation	1,593	840
Gross profit	6,338	4,478
Enterprise | Operating Segments
Segment Reporting Information [Line Items]
Revenue	95,242	64,911
Segment cost of revenue	32,867	22,163
Gross profit	62,375	42,748
Reconciliation of segment gross profit to gross profit
Gross profit	62,375	42,748
Consumer | Operating Segments
Segment Reporting Information [Line Items]
Revenue	81,188	87,312
Segment cost of revenue	37,496	39,797
Gross profit	43,692	47,515
Reconciliation of segment gross profit to gross profit
Gross profit	$ 43,692	$ 47,515

Segment and geographic inform_5

Segment and geographic information - Summary of Revenue by Region (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Segment Reporting Information [Line Items]
Revenue	$ 176,430	$ 152,223
North America
Segment Reporting Information [Line Items]
Revenue	71,707	60,588
Europe, Middle East, Africa
Segment Reporting Information [Line Items]
Revenue	54,551	47,725
Asia Pacific
Segment Reporting Information [Line Items]
Revenue	38,159	33,188
Latin America
Segment Reporting Information [Line Items]
Revenue	$ 12,013	$ 10,722

Segment and geographic inform_6

Segment and geographic information - Summary of Long-lived Assets by Region (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Segment Reporting Information [Line Items]
Total long-lived assets	$ 16,016	$ 18,338
North America
Segment Reporting Information [Line Items]
Total long-lived assets	11,083	12,782
Rest of world
Segment Reporting Information [Line Items]
Total long-lived assets	$ 4,933	$ 5,556

Restructuring charges (Details)

Restructuring charges (Details) - USD ($) $ in Thousands		3 Months Ended
	Feb. 13, 2023	Mar. 31, 2023	Mar. 31, 2022
Restructuring Cost and Reserve [Line Items]
Reduction in global workforce, percent	10%
Restructuring charges		$ 10,128	$ 0
Employee Severance
Restructuring Cost and Reserve [Line Items]
Restructuring charges		$ 8,920

Restructuring charges - Summary

Restructuring charges - Summary of Restructuring Charges (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Restructuring Reserve [Roll Forward]
Restructuring charges	$ 10,128	$ 0
Employee Severance
Restructuring Reserve [Roll Forward]
Beginning balance	0
Restructuring charges	8,920
Settlements	(4,376)
Ending balance	4,544
Share-Based Payment Arrangement
Restructuring Reserve [Roll Forward]
Restructuring charges	$ 1,200